Apex on stronger footing; expands pharmaceutical, consumer products


CEO of Apex Healthcare Bhd, Dr Kee Kirk Chin. - Art Chen/ The Star, 10 June 2014.

PETALING JAYA: Apex Healthcare Bhd’s transformation into a healthcare group from a pharmaceutical-based company has put it on a stronger footing in terms of revenue and earnings.

Chairman and chief executive officer Dr Kee Kirk Chin says Apex’s objective is to be an important regional player by growing the pharmaceutical, consumer products and orthopaedics business and increasing its exports.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Corporate News , Apex Pharmacy , earnings , 7090 ,

   

Next In Business News

China c.bank urges financial institutions to guard against rate risks in bond market
Honda, Nissan in talks to set up holding company
Malaysia hopes palm oil industry can be compliant with EU law when grace period ends
CIMB Bank and PayNet launch Malaysia’s first payment terminal with automated e-invoice capability
Property market shows stronger recovery signs
T7 Global appointed PETRONAS Panel Contractor for well continuity services
Scientex posts RM128.6mil net profit for 1Q25
ACE Market-bound Northern Solar aims to raise RM42.4mil from IPO
FBM KLCI rebounds above 1,600-point mark at midday
MIDA's commitment to investors - a stronger, more unified investment landscape

Others Also Read